logo
logo

Yemaachi, Africa’s Cancer Research Company, Raises Seed Round To Diversify Genomic Datasets & Advance Precision Oncology Globally

Mar 21, 2022•over 3 years ago

Round Type

seed

Accra

Description

Yemaachi Biotech, a cancer research and diagnostics company headquartered in Accra, Ghana with offices in Washington, DC, announced today the close of a $3 million seed round to advance its mission of diversifying precision oncology globally. V8 Capital led the round, with LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital and Ethan Perlstein also participating.

Company Information

Company

Yemaachi

Location

Accra, Greater Accra Region, Ghana

About

Yemaachi Biotech is a cancer research company committed to diversifying and increasing access to precision oncology. Using cutting-edge immunogenomics, bioinformatics, and artificial intelligence, Yemaachi is dedicated to accelerating the development of cancer detection and cure strategies which have high efficacy regardless of ethnicity. Headquartered in Accra, with a growing network of partners across Africa, Yemaachi is committed to building sustainable research and community partnerships that aid in the advancement of medicine and ultimately reduce the burden of cancer in Africa. Yemaachi was one of 15 African companies to be selected as part of the Summer 2021 batch of Y Combinator. For more information, visit www.yemaachi.com.